Microbot Medical Inc. Research And Development Expense

• Microbot Medical Inc. showed a decrease of -5.2% in Research And Development Expense from 2024 to 2025.
• This data is from Microbot Medical Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
• XBRL data for this metric is available from 2009 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 18 years of available data (2009 to 2025), Microbot Medical Inc.'s Research And Development Expense has declined by 68.5%.
• Historical annual values: Fiscal year 2025: $6.28 million | Fiscal year 2024: $6.63 million | Fiscal year 2023: $5.72 million | Fiscal year 2022: $7.74 million | Fiscal year 2021: $6.15 million | Fiscal year 2020: $3.40 million | Fiscal year 2019: $3.05 million | Fiscal year 2018: $2.52 million | Fiscal year 2017: $1.10 million | Fiscal year 2016: -$901.0 thousand | Fiscal year 2015: -$823.0 thousand | Fiscal year 2014: $21.50 million | Fiscal year 2014: $21.50 million | Fiscal year 2013: $19.37 million | Fiscal year 2012: $14.68 million | Fiscal year 2011: $19.94 million | Fiscal year 2010: $21.02 million | Fiscal year 2009: $19.93 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026